K2K Law represents companies and patent owners in U.S. patent infringement disputes. Our New York partners bring technical analysis and courtroom experience to matters involving technology, pharmaceuticals, and life sciences.
An accusation can affect a product, a customer relationship, or an operating budget. We assess the asserted claims, accused technology, procedural posture, and available defenses alongside the business’s priorities. The initial work identifies what needs investigation and how to coordinate with your existing legal team.
For a patent owner, a credible enforcement strategy starts with evidence. We examine ownership, claim scope, potential infringement, and litigation exposure before recommending a course. The objective may be a negotiated license, a focused dispute, or further diligence before a campaign proceeds.
The work depends on the dispute. A useful early assessment sets priorities for the next stage rather than assuming every matter follows the same path.
Review public patent and case materials, the parties’ positions, the relevant products, and the business constraints. Identify urgent procedural questions for counsel and the evidence still needed.
Investigate claim construction, infringement, validity, and enforceability. Plan the factual and expert work needed to support the selected positions.
Align district court strategy with related Patent Trial and Appeal Board proceedings where relevant. Consistent evidence and positions matter across the dispute.
Use discovery, expert analysis, motions, and negotiations to reassess the options. Prepare for trial and appeal when the matter calls for them.
The firm’s practice spans software, computer-implemented inventions, telecommunications, networking, wireless systems, electronics, and semiconductors. Technical investigation serves a legal position and a commercial objective.
K2K also handles disputes involving drug formulations, compositions, methods of treatment, and manufacturing processes. The partners’ complementary practices support work across these sectors.
Gaston Kroub brings a focus on pharmaceutical and life-sciences litigation alongside a broad technology practice. Sergey Kolmykov focuses on high-technology disputes, including software and telecommunications patents.
The engagement begins with a discussion of fit, scope, and staffing. Companies and patent owners outside New York can contact the firm about U.S. patent matters.
For the firm’s commentary on current disputes, read Patent Pulse. Reported cases are commentary, not a list of K2K representations.
Identify yourself, your organization, and the general nature of the dispute. Public patent or case identifiers can help with an initial discussion. Please leave confidential documents and time-sensitive instructions out of the web form.
K2K’s practice includes patent infringement defense and enforcement. Representation depends on conflicts review, fit, and an agreed engagement.
Yes. Owners considering enforcement can begin by discussing a patent portfolio diligence engagement to identify assets and questions that warrant closer investigation.
Read the guide to choosing patent litigation counsel →
Public checklists and questions to help organize a first discussion with counsel.
Share a brief, nonconfidential overview. We can discuss fit and the scope of a prospective engagement.